The latest research from Fore Pharma, France Pancreatic Cancer Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Pancreatic Cancer pipeline products, Pancreatic Cancer epidemiology, Pancreatic Cancer market valuations and forecast, Pancreatic Cancer products sales and competitive landscape in France.
The research is classified into nine sections – Pancreatic Cancer overview including etiology, pathophysiology, and diagnosis, Pancreatic Cancer treatment options, Pancreatic Cancer pipeline products, Pancreatic Cancer market analysis comprising of Pancreatic Cancer epidemiology, key products marketed for Pancreatic Cancer, market valuations and forecast, products sales and market shares.
Research Scope: - Pancreatic Cancer Pipeline: Find out the products in clinical trials for the treatment of Pancreatic Cancer by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products - Pancreatic Cancer Epidemiology: Find out the number of patients diagnosed (prevalence) with Pancreatic Cancer in France - Pancreatic Cancer Products: Identify key products marketed and prescribed for Pancreatic Cancer in France, including trade name, molecule name, and company - Pancreatic Cancer Product Sales: Find out the sales revenues of Pancreatic Cancer products, both branded and generics, in France - Pancreatic Cancer Market Valuations: Find out the market size for Pancreatic Cancer products in 2015 in France. Find out how the market advanced from 2010 and forecast to 2020 - Pancreatic Cancer Products Market Share: Find out the market shares for key Pancreatic Cancer products in France
Benefits of this Research: The research helps executives to - Support monitoring and reporting national Pancreatic Cancer market analysis and sales trends - Track competitor drugs sales and market share in France Pancreatic Cancer market - Track competitive developments in Pancreatic Cancer market and present key issues and learnings - Synthesize insights for Pancreatic Cancer market and products to drive business performance - Answer key business questions about the Pancreatic Cancer market - Evaluate commercial market opportunity assessment, positioning, and segmentation for Pancreatic Cancer products - Supports decision making in R&D to long term marketing strategies
Our reports have been used by over 10K customers, including:
Pancreatic Cancer Therapeutics Market Research Report by Product (Chemotherapy and Targeted Therapy), by Type (Endocrine Pancreatic Cancer and Exocrine Pancreatic cancer) - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market sizing and forecast across five major currencies...
Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Pancreatic Cancer Diagnostic Tests pipeline products...
Pancreatic Cancer - Epidemiology Forecast to 2029 Summary Pancreatic cancer (International Statistical Classification of Diseases and Related Health Problems, 10th Revision [ICD-10] code = C25) is the seventh leading cause of cancer deaths worldwide.Pancreatic cancer occurs when cells in the pancreas...
Heparanase - Pipeline Review, H2 2020 Summary Heparanase (Endo Glucoronidase or Heparanase 1 or HPSE or EC 3.2.1.166) pipeline Target constitutes close to 12 molecules. Out of which approximately 10 molecules are developed by companies and remaining by the universities/institutes. The latest report...
Fibroblast Growth Factor 2 - Pipeline Review, H2 2020 Summary Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2) pipeline Target constitutes close to 10 molecules. Out of which approximately 7 molecules are developed by companies and remaining by...
Non-Small Cell Lung Cancer - Epidemiology Forecast to 2029 Summary Lung cancer is a disease of uncontrolled cell growth in the lung tissues.It is one of the most commonly occurring cancers in the world (International Agency for Research on Cancer, 2018). There are two main types of lung cancer:...
Retinoblastoma - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Retinoblastoma - Pipeline Review, H2 2020, provides an overview of the Retinoblastoma (Oncology) pipeline landscape. Retinoblastoma is an eye cancer that begins in the retina....